European Union · Question · QUESTION_WRITTEN
E-9-2021-001806
New data requested for authorisation of the AstraZeneca COVID-19 vaccine in the US and Switzerland
Introduced
1 April 2021
Last action
7 July 2021 · Answer
Status
answered
Sponsors
Michèle RIVASI
Subjects
Discovery layer
Source updated
7 July 2021
Records
Official question E-9-2021-001806 from European Union at European Parliament. Dated 1 April 2021. Status: answered.
Timeline
1 April 2021
Written question
New data requested for authorisation of the AstraZeneca COVID-19 vaccine in the US and Switzerland
Source: QUESTION_WRITTEN
7 July 2021
Answer
Source: QUESTION_WRITTEN_ANSWER
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Answer
This file cannot be previewed here. Use View or Download.
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Answer
QUESTION_WRITTEN_ANSWER · 7 July 2021
New data requested for authorisation of the AstraZeneca COVID-19 vaccine in the US and Switzerland
QUESTION_WRITTEN · EN · 17 May 2021
DownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
New data requested for authorisation of the AstraZeneca COVID-19 vaccine in the US and Switzerland
QUESTION_WRITTEN · EN · 17 May 2021
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
New data requested for authorisation of the AstraZeneca COVID-19 vaccine in the US and Switzerland
QUESTION_WRITTEN · EN · 17 May 2021
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Demandes de données supplémentaires avant l’autorisation du vaccin AstraZeneca contre la COVID-19 aux États-Unis et en Suisse.
QUESTION_WRITTEN · FR · 17 May 2021
DownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Demandes de données supplémentaires avant l’autorisation du vaccin AstraZeneca contre la COVID-19 aux États-Unis et en Suisse.
QUESTION_WRITTEN · FR · 17 May 2021
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Demandes de données supplémentaires avant l’autorisation du vaccin AstraZeneca contre la COVID-19 aux États-Unis et en Suisse.
QUESTION_WRITTEN · FR · 17 May 2021
ViewDownloadOpen at official source
Reading translation
Translate this document into your language. PoliticalRepo does not store a separate copy per EU language.
On-demand whole-document translation with a downloadable PDF (logo + link to the official source). The official file stays authoritative.
Sponsors
- · EU_COMMISSION · ADDRESSEE
- Michèle RIVASI · AUTHOR
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.europarl.europa.eu/doceo/document/E-9-2021-001806_EN.html
- Open data entity: https://data.europarl.europa.eu/api/v2/parliamentary-questions/E-9-2021-001806
- eu · E-9-2021-001806 · source updated 7 July 2021